2bind

2bind is a specialized, privately-held CRO based in Regensburg, Germany, offering integrated and stand-alone discovery services for small molecules and antibodies. The company leverages a scalable, digitalized assay platform to deliver high-speed, high-quality data, aiming to be 'the fastest CRO in the world' for small molecules and 'the most trusted CRO' for antibody development. Its ISO 9001-certified services are designed to de-risk preclinical programs and accelerate client decision-making for biotech and pharma innovators. As a service provider, its financial model is based on project fees, placing it in a revenue-generating stage.

Scalable, digitalized assay platform for molecular interaction analysis, supporting target purification, biophysical binding characterization (e.g., SPR), screening, developability assessment, and pre-formulation studies for small molecules and antibodies.

2bind competes in a crowded CRO market, ranging from large, full-service organizations (e.g., LabCorp, IQVIA) to niche biophysical analysis specialists. Its differentiation is based on claims of superior speed for small molecules and high trust/reliability for antibodies, supported by ISO-certified processes and digital workflows.